Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Mi-Ae | - |
dc.contributor.author | Chung, Jong-Won | - |
dc.contributor.author | Yeon, Je Young | - |
dc.contributor.author | Kim, Jong-Soo | - |
dc.contributor.author | Hong, Seung Chyul | - |
dc.contributor.author | Bang, Oh Young | - |
dc.contributor.author | Ki, Chang-Seok | - |
dc.date.accessioned | 2021-08-11T14:44:09Z | - |
dc.date.available | 2021-08-11T14:44:09Z | - |
dc.date.issued | 2017-06-15 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7444 | - |
dc.description.abstract | Purpose Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by stenosis of the internal carotid arteries with compensatory development of collateral vessels. Although a founder variant of RNF213, p.Arg4810Lys (c.14429G>A, rs112735431), is a major genetic risk factor for MMD in East Asians, the frequency and disease susceptibility of other variants in this gene remain largely unknown. In the present study, we investigated the association of RNF213 variants with MMD in Korean patients and population controls. Methods For all RNF213 variants listed in the Human Gene Mutation Database (HGMD) as disease-causing or likely disease-causing mutations for MMD, genotyping was performed using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Genetic data from 264 adult patients with MMD were analyzed and compared with two control populations comprised of 622 and 1,100 Korean individuals, respectively. Results Among the 30 RNF213 variants that were listed in the HGMD, p.Arg4810Lys was identified in 67.4% (178/264) of patients with MMD and showed a significantly higher allele frequency than in the controls, giving an odds ratio of 63.29 (95% confidence interval, 33.11-120.98) for the 622 controls and 48.55 (95% confidence interval, 31.00-76.03) for the 1100 controls. One additional variant, p.Ala5021Val (c.15062C>T, rs138130613), was identified in 0.8% (2/264) of patients; however, the allele frequencies were not significantly different from those in the controls. Conclusions These results suggest that, in our cohort of Korean patients, the p.Arg4810Lys is the only variant that is strongly associated with MMD among the 30 RNF213 variants listed in the HGMD. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Public Library of Science | - |
dc.title | Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1371/journal.pone.0179689 | - |
dc.identifier.scopusid | 2-s2.0-85021128097 | - |
dc.identifier.wosid | 000403364600055 | - |
dc.identifier.bibliographicCitation | PLoS ONE, v.12, no.6 | - |
dc.citation.title | PLoS ONE | - |
dc.citation.volume | 12 | - |
dc.citation.number | 6 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | LEADS | - |
dc.subject.keywordAuthor | Frequency | - |
dc.subject.keywordAuthor | significance | - |
dc.subject.keywordAuthor | rare RNF213 variants | - |
dc.subject.keywordAuthor | adult moyamoya | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.